<p>Systemic lupus erythematosus (SLE) is an autoimmune disease posing a significant threat to human health. Regulatory T cells (Tregs) are crucial for immune homeostasis. Dysfunction of Tregs have been demonstrated in SLE, but underlying mechanisms remain largely unclear. Here, we observe that peripheral Treg numbers and SLC7A11 expression in Tregs are reduced in SLE, with SLC7A11 levels negatively correlates with disease activity. Treg-specific SLC7A11 deletion impairs their stability and differentiation, promotes a pro-inflammatory phenotype, thereby aggravating autoantibody production and lupus progression in mice. Mechanistically, mild SLC7A11 inhibition stabilizes HIF-1α, enhances glycolysis and increases pro-inflammatory cytokines in Tregs. Severe SLC7A11 inhibition causes excessive lipid peroxidation and ferroptosis. In summary, our findings suggest that SLE Tregs with reduced SLC7A11 expression may undergo varying degrees of damage. Specifically, mild SLC7A11 deficiency drives glycolysis and Treg instability, whereas severe deficiency triggers ferroptosis. Upregulating SLC7A11 expression may be a promising therapeutic strategy for SLE.</p><p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

SLC7A11 deficiency exacerbates systemic lupus erythematosus by inducing instability and ferroptosis in regulatory T cells

  • Lianlian Ouyang,
  • Fangqi Chen,
  • Meiling Zheng,
  • Zhi Hu,
  • Xiaoli Min,
  • Yang Song,
  • Xiaofei Gao,
  • Xiaoyun Chen,
  • Qiaolin Wang,
  • Qianjin Lu,
  • Ming Zhao

摘要

Systemic lupus erythematosus (SLE) is an autoimmune disease posing a significant threat to human health. Regulatory T cells (Tregs) are crucial for immune homeostasis. Dysfunction of Tregs have been demonstrated in SLE, but underlying mechanisms remain largely unclear. Here, we observe that peripheral Treg numbers and SLC7A11 expression in Tregs are reduced in SLE, with SLC7A11 levels negatively correlates with disease activity. Treg-specific SLC7A11 deletion impairs their stability and differentiation, promotes a pro-inflammatory phenotype, thereby aggravating autoantibody production and lupus progression in mice. Mechanistically, mild SLC7A11 inhibition stabilizes HIF-1α, enhances glycolysis and increases pro-inflammatory cytokines in Tregs. Severe SLC7A11 inhibition causes excessive lipid peroxidation and ferroptosis. In summary, our findings suggest that SLE Tregs with reduced SLC7A11 expression may undergo varying degrees of damage. Specifically, mild SLC7A11 deficiency drives glycolysis and Treg instability, whereas severe deficiency triggers ferroptosis. Upregulating SLC7A11 expression may be a promising therapeutic strategy for SLE.